Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Expensive Performer
1144.5000
1.90
(
0.17
%)
NSE
May 19, 2025
15:31 PM
51.40% Gain from 52W Low
Volume:
139.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
24 Jul 2021
1144.50
0.17%
GLENMARK LIFE SCIENCES LTD
IPO Note:
Alivus Life Sciences Ltd.
by
Ventura
Ventura
IPO NOTE
Number of MF schemes increased from 11 to 18 in Mar 2025 qtr.
More from Alivus Life Sciences Ltd.
Recommended
Market closes lower, Zydus Wellness' Q4 net profit grows 14.4% YoY to Rs 171.9 crore
Trendlyne Marketwatch |
19 May 2025, 03:58PM
IPOs This Week: Belrise Industries, Borana Weaves Plus Two New Issues, and Two Listings Ahead
|
19 May 2025, 02:36PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021